853 Followers on Owler

Intellia

Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases... Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Intellia

Therapeutics is a Massachusetts-based biotechnology company that researches and develops genome editing therapies to treat genetic and oncological diseases... Read more
Intellia President & CEO: John Leonard

President & CEO

John Leonard

CEO Approval Rating

82/100

2014

PublicNASDAQNTLA

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$57.9M
Employees
600
Funding
$883M
Acquisitions
1
Investments
2

News

Layoffs
Jan 10, 2025
BioPharma Dive
Intellia to stop work on rare disease therapy, lay off staff
Partnership
Nov 19, 2024
Pharamceutical Technology
ReCode to secure funds for cystic fibrosis gene correction treatments

Intellia Competitors

1Beam
2CRISPR
3Caribou
4Editas Medicine
5ToolGen
6Allogene
7bluebird bio
8Cellectis
Unlock 5 + competitors

Trending Companies